1609 related articles for article (PubMed ID: 17974436)
1. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of different effects of sera of breast cancer patients on the activity of natural killer cells.
Konjević G; Spuzić I
J Clin Lab Immunol; 1992; 38(2):83-93. PubMed ID: 1343351
[TBL] [Abstract][Full Text] [Related]
3. [Immunomodulatory effect of serum on NK cells in vitro in healthy individuals].
Konjević G; Spuzić I
Glas Srp Akad Nauka Med; 1994; (44):45-54. PubMed ID: 7590414
[TBL] [Abstract][Full Text] [Related]
4. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer.
Konjević G; Spuzić I
Neoplasma; 1993; 40(2):81-5. PubMed ID: 8350959
[TBL] [Abstract][Full Text] [Related]
5. [The possibilities of modulation of NK cell activity].
Konjević G; Spuzić I
Glas Srp Akad Nauka Med; 2002; (47):89-101. PubMed ID: 16078444
[TBL] [Abstract][Full Text] [Related]
6. [The effect of serum on NK cell activity].
Konjević G; Spuzić I
Glas Srp Akad Nauka Med; 1991; (41):113-20. PubMed ID: 1916438
[TBL] [Abstract][Full Text] [Related]
7. [The significance of determination of NK cell activity in malignant diseases].
Spuzić I; Konjević G
Glas Srp Akad Nauka Med; 1990; (39):153-60. PubMed ID: 2130019
[TBL] [Abstract][Full Text] [Related]
8. Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.
Pislarasu M; Oproiu A; Taranu D; Herberman RB; Sulica A
Cancer Res; 1988 May; 48(9):2596-603. PubMed ID: 3356020
[TBL] [Abstract][Full Text] [Related]
9. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum.
Lauer SJ; Finlan J; Borella LD; Piaskowski VD; Casper JT
J Clin Lab Immunol; 1983 Oct; 12(2):105-10. PubMed ID: 6606047
[TBL] [Abstract][Full Text] [Related]
10. [Alterations in NK cell activity in the presence of sera of patients with metastases].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1994; 122 Suppl 1():78-80. PubMed ID: 18173196
[TBL] [Abstract][Full Text] [Related]
11. Immune responses to guided imagery during breast cancer treatment.
Lengacher CA; Bennett MP; Gonzalez L; Gilvary D; Cox CE; Cantor A; Jacobsen PB; Yang C; Djeu J
Biol Res Nurs; 2008 Jan; 9(3):205-14. PubMed ID: 18077773
[TBL] [Abstract][Full Text] [Related]
12. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
[TBL] [Abstract][Full Text] [Related]
14. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
Shau H; Isacescu V; Ibayashi Y; Tokuda Y; Golub SH; Fahey JL; Sarna GP
J Biol Response Mod; 1990 Feb; 9(1):71-80. PubMed ID: 2319261
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
Bonavida B; Katz J; Gottlieb M
J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
19. Assessment of host immune response in breast cancer patients.
Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
[TBL] [Abstract][Full Text] [Related]
20. Decreased response to interleukin-2 of cancer patients in terms of augmentation of natural killer cell activity.
Abe Y; Ajitsu S; Hamuro J; Ishikawa M; Sendo F
Jpn J Cancer Res; 1985 Oct; 76(10):1003-7. PubMed ID: 3935618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
